Therapeutic use of convalescent plasma in COVID-19 patients with immunodeficiency: A systematic review
暂无分享,去创建一个
A. Casadevall | L. Pirofski | N. Paneth | R. Carter | M. Joyner | J. P. Henderson | B. Bostrom | R. Wright | M. Thompson | D. Fairweather | W. Nicholson | S. Klassen | J. Senefeld | C. Wiggins | S. Baker | K. A. Bruno | P. Johnson | W. Hartman | S. K. Ford | S. Ford | J. Senefeld
[1] M. Addo,et al. Sustained response after remdesivir and convalescent plasma therapy in a B-cell depleted patient with protracted COVID-19 , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] T. Bhatnagar,et al. Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial) , 2020, BMJ.
[3] F. Simeone,et al. Safety and efficacy of COVID‐19 convalescent plasma in severe pulmonary disease: A report of 17 patients , 2020, Transfusion medicine.
[4] G. Pugliese,et al. Severe COVID-19 in Third Trimester Pregnancy: Multidisciplinary Approach , 2020, Case reports in critical care.
[5] Arvind Singh Tomar,et al. COVID-19 in Liver Transplant Recipients - A Series with Successful Recovery , 2020, Journal of clinical and translational hepatology.
[6] T. Luetkens,et al. Successful transfer of anti–SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19 , 2020, Blood Advances.
[7] M. Graham,et al. Bronchoalveolar lavage-based COVID-19 testing in patients with cancer , 2020, Hematology/Oncology and Stem Cell Therapy.
[8] R. Olsen,et al. Early transfusion of a large cohort of COVID-19 patients with high titer anti-SARS-CoV-2 spike protein IgG convalescent plasma confirms a signal of significantly decreased mortality , 2020, medRxiv.
[9] Booth Wainscoat,et al. A 63-Year-Old Woman with a History of Non-Hodgkin Lymphoma with Persistent SARS-CoV-2 Infection Who Was Seronegative and Treated with Convalescent Plasma , 2020, The American journal of case reports.
[10] J. Mascarenhas,et al. Severe COVID-19 virus reactivation following treatment for B cell acute lymphoblastic leukemia , 2020, Journal of Hematology & Oncology.
[11] R. Carter,et al. In Reply — Limitations of Safety Update on Convalescent Plasma Transfusion in COVID-19 Patients , 2020, Mayo Clinic Proceedings.
[12] W. Geng,et al. Convalescent Plasma Rescued a Severe COVID-19 Patient with Chronic Myeloid Leukemia Blast Crisis and Myelofibrosis. , 2020, Turkish journal of haematology : official journal of Turkish Society of Haematology.
[13] D. Yokoe,et al. Treatment of immunocompromised COVID‐19 patients with convalescent plasma , 2020, Transplant infectious disease : an official journal of the Transplantation Society.
[14] H. Trimarchi,et al. Eculizumab, SARS-CoV-2 and atypical hemolytic uremic syndrome , 2020, Clinical kidney journal.
[15] N. Radhakrishnan,et al. Convalescent plasma to aid in recovery of COVID-19 pneumonia in a child with acute lymphoblastic leukemia , 2020, Transfusion and Apheresis Science.
[16] B. Lambrecht,et al. Coronavirus disease 2019 in patients with inborn errors of immunity: An international study , 2020, Journal of Allergy and Clinical Immunology.
[17] C. Wobus,et al. Prolonged SARS-CoV-2 replication in an immunocompromised patient , 2020, medRxiv.
[18] P. Gallian,et al. Convalescent plasma therapy for B-cell–depleted patients with protracted COVID-19 , 2020, Blood.
[19] Nicole M. Bouvier,et al. Convalescent Plasma for the Treatment of Severe COVID‐19 Infection in Cancer Patients , 2020, Cancer Medicine.
[20] C. Cordon-Cardo,et al. Three patients with X-linked agammaglobulinemia hospitalized for COVID-19 improved with convalescent plasma , 2020, The Journal of Allergy and Clinical Immunology: In Practice.
[21] Nicole M. Bouvier,et al. Treatment with convalescent plasma in solid organ transplant recipients with COVID‐19: Experience at large transplant center in New York City , 2020, Clinical transplantation.
[22] S. Stowell,et al. COVID-19 convalescent plasma clears SARS-CoV-2 refractory to remdesivir in an infant with congenital heart disease , 2020, Blood Advances.
[23] K. Sullivan,et al. Convalescent plasma for pediatric patients with SARS-CoV-2-associated acute respiratory distress syndrome , 2020, Pediatric blood & cancer.
[24] Z. Kashi,et al. Coronavirus Disease 2019 Viremia, Serologies, and Clinical Course in a Case Series of Transplant Recipients , 2020, Transplantation Proceedings.
[25] J. Bailey,et al. Successful recovery from COVID‐19 in three kidney transplant recipients who received convalescent plasma therapy , 2020, Transplant infectious disease : an official journal of the Transplantation Society.
[26] E. Aksoy,et al. COVID-19 Presentation in Association with Myasthenia Gravis: A Case Report and Review of the Literature , 2020, Case reports in infectious diseases.
[27] A. Casadevall,et al. Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience , 2020, medRxiv.
[28] E. Bloch. Convalescent plasma to treat COVID-19 , 2020, Blood.
[29] A. Saburi,et al. Convalescent plasma therapy in a pregnant COVID-19 patient with a dramatic clinical and imaging response: A case report , 2020, World journal of radiology.
[30] M. Salesi,et al. Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study , 2020, Transfusion and Apheresis Science.
[31] C. Ortega,et al. Rapid recovery of a SARS-CoV-2–infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma , 2020, The Journal of Allergy and Clinical Immunology: In Practice.
[32] S. Aksu,et al. Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma , 2020, Transfusion and Apheresis Science.
[33] M. M. van der Eerden,et al. Convalescent Plasma for COVID-19. A randomized clinical trial , 2020, medRxiv.
[34] P. Zhou,et al. Convalescent plasma therapy: Helpful treatment of COVID‐19 in a kidney transplant recipient presenting with severe clinical manifestations and complex complications , 2020, Clinical transplantation.
[35] G. Cartron,et al. Convalescent plasma for persisting COVID‐19 following therapeutic lymphocyte depletion: a report of rapid recovery , 2020, British journal of haematology.
[36] A. Cap,et al. Successful Use of COVID-19 Convalescent Plasma in a Patient Recently Treated for Follicular Lymphoma , 2020, Clinical Lymphoma Myeloma and Leukemia.
[37] Alex K. Williamson,et al. COVID‐19 in recent heart transplant recipients: Clinicopathologic features and early outcomes , 2020, Transplant infectious disease : an official journal of the Transplantation Society.
[38] A. Hess,et al. Hospitalized COVID-19 patients treated with Convalescent Plasma in a mid-size city in the midwest , 2020, medRxiv.
[39] N. Saba,et al. COVID-19 in allogeneic stem cell transplant: high false-negative probability and role of CRISPR and convalescent plasma , 2020, Bone Marrow Transplantation.
[40] M. Brodmann,et al. Response to “COVID-19 in persons with haematological cancers” , 2020, Leukemia.
[41] S. Jagannath,et al. A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward , 2020, medRxiv.
[42] L. Ren,et al. Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial. , 2020, JAMA.
[43] S. Aksu,et al. Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosis , 2020, Transfusion and Apheresis Science.
[44] T. Lv,et al. Treatment with convalescent plasma for COVID‐19 patients in Wuhan, China , 2020, Journal of medical virology.
[45] Wayne T. Nicholson,et al. Deployment of convalescent plasma for the prevention and treatment of COVID-19. , 2020, The Journal of clinical investigation.
[46] He Huang,et al. Mechanisms and rejuvenation strategies for aged hematopoietic stem cells , 2020, Journal of Hematology & Oncology.
[47] Arturo Casadevall,et al. The convalescent sera option for containing COVID-19. , 2020, The Journal of clinical investigation.
[48] Smita Y. Patel,et al. The Expanding Field of Secondary Antibody Deficiency: Causes, Diagnosis, and Management , 2019, Front. Immunol..
[49] E. Gelfand,et al. Common Variable Immunodeficiency: Diagnosis, Management, and Treatment. , 2015, Immunology and allergy clinics of North America.
[50] Kwok-Hung Chan,et al. Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[51] S. Hoffman,et al. Meta-Analysis: Convalescent Blood Products for Spanish Influenza Pneumonia: A Future H5N1 Treatment? , 2006, Annals of Internal Medicine.
[52] P. Chan,et al. Use of convalescent plasma therapy in SARS patients in Hong Kong , 2004, European Journal of Clinical Microbiology and Infectious Diseases.